BRISTOL-MYERS SQUIBB v. TEVA PHARMACEUTICALS USA

No. 2013-1306.

752 F.3d 967 (2014)

BRISTOL-MYERS SQUIBB COMPANY, Plaintiff-Appellant, v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellee.

United States Court of Appeals, Federal Circuit.

June 12, 2014.


Attorney(s) appearing for the Case

William F. Lee , Wilmer Cutler Pickering Hale and Dorr LLP, of Boston, MA, argued for plaintiff-appellant. With him on the brief were Lauren B. Fletcher and Andrew J. Danford ; Amy K. Wigmore and Thomas G. Saunders , of Washington, DC. Of counsel on the brief were Paul Berghoff , Alison J. Baldwin , and Joshua R. Rich , McDonnell Boehnen Hulbert & Berghoff LLP, of Chicago, IL.

George C. Lombardi , Winston & Strawn LLP, of Chicago, IL, argued for defendant-appellee. With him on the brief were Lynn MacDonald Ulrich , Ivan M. Poullaos , Julia Mano Johnson , and William P. Ferranti.

Before PROST, Chief Judge, PLAGER and CHEN, Circuit Judges.


CHEN, Circuit Judge.

This patent infringement case concerns a drug for the treatment of hepatitis B. After a four-day bench trial, the United States District Court for the District of Delaware found claim 8 of U.S. Patent No. 5,206,244 ('244 patent) invalid as obvious. We affirm the district court's invalidity judgment for the reasons that follow.

I.

Appellant Bristol-Myers Squibb Co. (BMS) owns the '244 patent. Claim 8 of the '244 patent is directed...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases